medRxiv. co-auth.:A.Reymond

Genetic modifiers and ascertainment drive variable expressivity of complex disorders

Matthew Jensen 1 2Corrine Smolen 1 2Anastasia Tyryshkina 1Lucilla Pizzo 1Deepro Banerjee 1Matthew Oetjens 3Hermela Shimelis 3Cora M Taylor 3Vijay Kumar Pounraja 1 2Hyebin Song 4Laura Rohan 1Emily Huber 1Laila El Khattabi 5Ingrid van de Laar 6Rafik Tadros 6Connie Bezzina 6Marjon van Slegtenhorst 6Janneke Kammeraad 6Paolo Prontera 7Jean-Hubert Caberg 8Harry Fraser 9Siddhartha Banka 9 10Anke Van Dijck 11Charles Schwartz 12Els Voorhoeve 13Patrick Callier 14Anne-Laure Mosca-Boidron 14Nathalie Marle 14Mathilde Lefebvre 15Kate Pope 16Penny Snell 16Amber Boys 16Paul J Lockhart 16 17Myla Ashfaq 18Elizabeth McCready 19Margaret Nowacyzk 19Lucia Castiglia 20Ornella Galesi 20Emanuela Avola 20Teresa Mattina 20Marco Fichera 20 21Maria Grazia Bruccheri 20Giuseppa Maria Luana Mandarà 22Francesca Mari 23Flavia Privitera 23Ilaria Longo 23Aurora Curró 23Alessandra Renieri 23Boris Keren 24Perrine Charles 24Silvestre Cuinat 25Mathilde Nizon 25Olivier Pichon 25Claire Bénéteau 25Radka Stoeva 25Dominique Martin-Coignard 26Sophia Blesson 27Cedric Le Caignec 28 29Sandra Mercier 27Marie Vincent 27Christa Martin 3Katrin Mannik 30 31Alexandre Reymond 32Laurence Faivre 14 15Erik Sistermans 13R Frank Kooy 11David J Amor 13Corrado Romano 20 21Joris Andrieux 33Santhosh Girirajan 1 2 34

[Preprint]. 2024 Aug 28:2024.08.27.24312158.

 doi: 10.1101/2024.08.27.24312158.

Abstract

Variable expressivity of disease-associated variants implies a role for secondary variants that modify clinical features. We assessed the effects of modifier variants towards clinical outcomes of 2,252 individuals with primary variants. Among 132 families with the 16p12.1 deletion, distinct rare and common variant classes conferred risk for specific developmental features, including short tandem repeats for neurological defects and SNVs for microcephaly, while additional disease-associated variants conferred multiple genetic diagnoses. Within disease and population cohorts of 773 individuals with the 16p12.1 deletion, we found opposing effects of secondary variants towards clinical features across ascertainments. Additional analysis of 1,479 probands with other primary variants, such as 16p11.2 deletion and CHD8 variants, and 1,084 without primary variants, showed that phenotypic associations differed by primary variant context and were influenced by synergistic interactions between primary and secondary variants. Our study provides a paradigm to dissect the genomic architecture of complex disorders towards personalized treatment.